SYLVIA PASIEKA: Open Payments
NPI 1124327770 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$920 in 36 payments from 16 companies in 2025. Trend: 2023 $14 · 2024 $23 · 2025 $920
Food & beverage: $645Education: $275
| Company | Payments | Amount |
|---|---|---|
| SEAGEN INC. | 2 | $179 |
| SANOFI-AVENTIS U.S. LLC | 1 | $96 |
| Incyte Corporation | 4 | $90 |
| AstraZeneca Pharmaceuticals LP | 4 | $84 |
| Janssen Biotech, Inc. | 4 | $71 |
| TerSera Therapeutics LLC | 4 | $69 |
| PFIZER INC. | 3 | $57 |
| Stemline Therapeutics Inc. | 3 | $54 |
| TAIHO ONCOLOGY, INC. | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
Products named: SARCLISA, JAKAFI, ELREXFIO, Orserdu, Xermelo, ENHERTU, LONSURF, SCEMBLIX.
Industry payments across NJ — which companies pay providers there.
